Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis | Zendy

Karl V. Clemons | Zendy; L H Hanson | Zendy; A M Perlman | Zendy; David A. Stevens | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis

Author(s) -

Karl V. Clemons,

L H Hanson,

A M Perlman,

David A. Stevens

Publication year - 1990

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.34.5.928

Subject(s) - coccidioides immitis , fluconazole , coccidioides , medicine , antifungal , mycosis , clearance , pharmacokinetics , pharmacology , immunology , biology , microbiology and biotechnology , urology

The efficacies of SCH39304 (SCH) and fluconazole (FLU) were tested in a murine model of coccidioidomycosis. CD-1 mice were infected with Coccidioides immitis and dosed with SCH at 2, 10, 25, or 50 mg/kg per day or FLU at 10 or 100 mg/kg per day. Survival was enhanced (P less than 0.001) by both drugs at all doses. Residual burdens of C. immitis in the organs of mice treated with SCH at 25 or 50 mg/kg per day were lower than in mice treated with FLU at 100 mg/kg per day (P less than 0.001). These results indicate that SCH is an effective therapy for coccidioidomycosis and is superior to FLU in this comparison.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research